louisakewell, Author at European Medical Journal - Page 20 of 153

Repeated Tick Bites Influence Basophil Kinetics and Production of Specific IgE Antibody to Galactose-α-1,3-Galactose

The disaccharide galactose-α-1,3-galactose (alpha gal) is a typical component of glycoproteins in mammals. Since primates, including humans, have lost…

A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis

The objective of this study was to conduct a systematic review of the available evidence on the treatment of herpes simplex labialis with U.S. Food and Drug Administration (FDA)-approved topical antibiotics.

Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers

Chronic urticaria (CU) is characterised by intense recurrent itch, wheals, and/or angioedema, persisting for >6 weeks. CU can be subdivided into chronic…

Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis

Psoriasis is a common skin disease with various cutaneous manifestations and is classified into two clinical groups: non-pustular and pustular.

Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future

Considering patient-reported outcomes (PRO) for optimal disease management is pivotal in many chronic diseases, and inflammatory bowel disease (IBD) is…

Individualised Care for Crohn's Disease: Evolving Approaches for a Progressive Disease

This symposium focusses on understanding the advantages and limitations of current management strategies for Crohn’s disease.

Review of the 4th European Academy of Neurology Congress 2018

The 4th European Academy of Neurology (EAN) congress was held in the hilly, coastal capital of Lisbon, Portugal, on the 16th–19th June 2018.

Diagnosing Neuromuscular Diseases

The field of neuromuscular diseases (NMD) has evolved at an unprecedented speed over the last two decades. Due to advances in molecular genetics…

Neuropsychological and Brain Grey Matter Volume Changes After Computer-Assisted Cognitive Treatment in Patients with Multiple Sclerosis

Cognitive impairment is a common disorder in multiple sclerosis (MS), present in >65% of patients both in the early and advanced phases of the disease…

Congress Feature from EAN 2018

During this year’s EAN Congress, the EMJ team attended the much-anticipated final presidential symposium chaired by Prof Günther Deuschl as President of…